JPS56115717A - Preventive and remedy for prostatomegaly - Google Patents

Preventive and remedy for prostatomegaly

Info

Publication number
JPS56115717A
JPS56115717A JP1938680A JP1938680A JPS56115717A JP S56115717 A JPS56115717 A JP S56115717A JP 1938680 A JP1938680 A JP 1938680A JP 1938680 A JP1938680 A JP 1938680A JP S56115717 A JPS56115717 A JP S56115717A
Authority
JP
Japan
Prior art keywords
formula
prostatomegaly
remedy
preventive
monacholin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1938680A
Other languages
Japanese (ja)
Other versions
JPS6411617B2 (en
Inventor
Akira Endo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP1938680A priority Critical patent/JPS56115717A/en
Publication of JPS56115717A publication Critical patent/JPS56115717A/en
Publication of JPS6411617B2 publication Critical patent/JPS6411617B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: To provide a preventive and remedy for prostatomegaly, having extremely low toxicity and excellent cholesterol-lowering activity, by using monacholin K or ML-236B or their derivatives as effective component.
CONSTITUTION: Monacholin K of formula I, ML-236B of formula II or their derivatives [e.g. the carboxylic acid of formula III, a component of formula IV (M is metal element; n is valency of said element)] are used as effective components of a preventive and remedy for prostatomegaly. The above effective component can be administered singly or as a preparation in the form of powder, capsule, tablet, injection, etc. in combination with proper diluent, by oral administration, peritoneal infusion, intravenous injection, etc. Dose: 0.5W1,000mg/kg daily.
COPYRIGHT: (C)1981,JPO&Japio
JP1938680A 1980-02-19 1980-02-19 Preventive and remedy for prostatomegaly Granted JPS56115717A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1938680A JPS56115717A (en) 1980-02-19 1980-02-19 Preventive and remedy for prostatomegaly

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1938680A JPS56115717A (en) 1980-02-19 1980-02-19 Preventive and remedy for prostatomegaly

Publications (2)

Publication Number Publication Date
JPS56115717A true JPS56115717A (en) 1981-09-11
JPS6411617B2 JPS6411617B2 (en) 1989-02-27

Family

ID=11997848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1938680A Granted JPS56115717A (en) 1980-02-19 1980-02-19 Preventive and remedy for prostatomegaly

Country Status (1)

Country Link
JP (1) JPS56115717A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040334A (en) * 1992-05-13 2000-03-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040334A (en) * 1992-05-13 2000-03-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy

Also Published As

Publication number Publication date
JPS6411617B2 (en) 1989-02-27

Similar Documents

Publication Publication Date Title
ES2001706A6 (en) Peptide derivatives, process for the production thereof and pharmaceutical compositions containing same.
RU2059603C1 (en) Derivatives of &&&-substituted arylacetic acids and pharmaceutical composition
JPS5551020A (en) Remedy for rheumatism
JPS5767516A (en) Novel analgesic agent
EP0647616A4 (en) Zinc tranexamate compound.
JPS56115717A (en) Preventive and remedy for prostatomegaly
JPS57109721A (en) Carcinostatic agent
EP0334967A4 (en) Keratosis-treating agent
JPS5630917A (en) Preventive and remedy for hepatitis
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
ES8602654A1 (en) Medicines based on piperidine derivatives, piperidine derivatives and process for their preparation.
JPS6452721A (en) Diabetic remedy containing 7-thiapprostaglandin e1 as active ingredient
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS54132239A (en) Anti-tumor agent
JPS646214A (en) Remedy for ulcerative colonopathy
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS56150013A (en) Preventive and remedy for cancer
JPS5759808A (en) Remedy and preventive for digestive ulcer
JPS57128625A (en) Carcinostatic
JPS5589221A (en) Antihistaminic agent
JPS57167912A (en) Antitumor agent
JPS5498339A (en) Carcinostatic agent
JPS5569510A (en) Carcinostatic agent
JPS57144216A (en) Antiulcer
JPS6485915A (en) Hypotensor